Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1514-2024Class II

EndoVive 20Fr Push Standard PEG Kit w/ENFit (Box 2)-Indicated for enteral nutrition directly into the stomach...

Boston Scientific Corporation / initiated 2024-02-20 / Open, Classified / root cause: manufacturing process

Boston Scientific Corporation began a recall of EndoVive 20Fr Push Standard PEG Kit w/ENFit (Box 2)-Indicated for enteral nutrition directly into the stomach in both pediatric and adult patients who are... on . FDA classified it as Class II and gives the reason as "Inability to advance the guidewire through the feeding tube during placement due to blocked lumen of the barb connector. May lead prolongation in the procedure to exchange the device for another leading to leading to a...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1514-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Boston Scientific Corporation
Product
EndoVive 20Fr Push Standard PEG Kit w/ENFit (Box 2)-Indicated for enteral nutrition directly into the stomach in both pediatric and adult patients who are unable to consume nutrition by conventional means. UPN: M00509051
Product code
PIF Gastrointestinal Tubes With Enteral Specific Connectors
Reason for recall
Inability to advance the guidewire through the feeding tube during placement due to blocked lumen of the barb connector. May lead prolongation in the procedure to exchange the device for another leading to leading to a cascade of events which may include additional intervention to close the puncture site, bleeding, leakage of gastric contents, and aspiration
Root cause tag
manufacturing process
FDA root cause
Process design
Action
Boston Scientific issued Urgent Medical Device Removal letter on 2/20/24 via courier. Letter states reason for recall, health risk and action to take: is readily accessible to all handlers and users of the device. Share this notice with any health care professional within your organization and with any organization where the affected devices may have been transferred. This removal affects only the products listed in Attachment 1 (Affected Products). No other material numbers or batches are impacted by this removal. Further distribution or use of any remaining product affected by this removal should cease immediately. If you are a distributor, this notification must be forwarded to your customers to ensure notification of this product removal is carried out to the end-user level. If you are a facility that has sent products to another hospital or a facility within your network, ensure this notification is forwarded to them. Please read carefully through the Removal Instructions included with this notification. Affected products have been distributed as EndoViveTM Standard Push PEG and EndoViveTM Safety Push PEG Kit. If you are a facility that has received EndoViveTM Safety Push PEG Kits, the full (sealed) procedure kit must be returned. You will not receive credit for opened procedure kits. Your local sales representative can answer any questions you may have regarding this notification. If you have any further questions, please contact your local Boston Scientific sales representative.
Quantity in commerce
572 units
Distribution
Worldwide distribution - US Nationwide and the country of Japan.
Product codes and lots
GTIN: 08714729880493 Lot Numbers: 32162452, 32370861, 32714500

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1514-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1513-2024Class IIOngoingVoluntary: Firm initiated
Z-1514-2024Class IIOngoingVoluntary: Firm initiated
Z-1515-2024Class IIOngoingVoluntary: Firm initiated
Z-1516-2024Class IIOngoingVoluntary: Firm initiated
Z-1517-2024Class IIOngoingVoluntary: Firm initiated